Spirox (TWSE:3055), the sole and exclusive distributor of Xcerra Corporation (NASDAQ: XCRA) in China, Hong Kong and Taiwan, recently received an email message from Xcerra advising that Xcerra intends ...

Positive data supporting the use of Spirox's LATERA for the treatment of nasal valve collapse published in Facial Plastic Surgery "These results are very promising, as they demonstrate the safety and ...

HSINCHU, Feb. 18, 2025 /PRNewswire/ -- Spirox Corporation (TWSE: 3055), a professional semiconductor equipment provider announced its plan to build the first power semiconductor dynamic reliability ...

Entellus Medical announced the largest acquisition of its 11-year history on Friday: a more than $81 million deal for nasal airway obstruction device maker Spirox Inc. Per the agreement, ...

Spirox Inc., a privately held medical device company, announced today the closing of an $18.5 million Series B round of financing led by Venrock and Aisling Capital. Existing investors Aperture ...

Spirox roped in $18.5 million in a Series B round to support development of its nasal obstruction device, giving the company a boost as it eyes U.S. regulatory approval for its product. Venrock and ...

Spirox is touting results from a study of its Latera absorbable nasal implant, a device designed to fight nasal valve collapse and obstruction. Latera is an absorbable polymer implant that supports ...

Taiwan-based Spirox and Molecular Sensoring Technology (Molsentech) have announced their joint development of a MOSFET-based COVID-19 rapid test system, which is slated for launch at the end of 2020.

California-based Spirox Inc. announced today that it has finalized a $45 million Series C round of financing, which will be used to move forward with its minimally invasive system to be used by Ear, ...

MENLO PARK, Calif., May 16, 2016 /PRNewswire/ — Spirox, Inc., a privately held medical device company, announced today the appointment of Neil Hattangadi, M.D., as president and chief operating ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Spirox Inc., a privately held medical device company, announced today the closing of a $45 million Series C round of financing led by KKR, a leading global ...

Credence Systems and Spirox, a provider of IC design, fabrication, and assembly and test for the semiconductor and TFT-LCD high-tech industries, have announced that they will combine Credence's Taiwan ...